Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 May 2024 | Story ANTHONY MTHEMBU | Photo Supplied
Ibrahim Mahama
Contemporary artist Ibrahim Mahama engaging with students during his visit to the Department of Fine Arts at the University of the Free State (UFS).

Ghanaian contemporary artist, Ibrahim Mahama, visited the Department of Fine Arts at the University of the Free State (UFS) to share insights with staff and students during his stay in the country.

Dr Adelheid Von Maltitz, Senior Lecturer in the Department of Fine Arts at the UFS, highlighted the significance of Mahama’s visit which took place from 21 to 28 March 2024, marking the first instance of such interaction between a Fine Arts department in South Africa and Mahama. She remarked, “It is truly astounding that a person of his calibre dedicated time to focus on our department, and I believe this has catalysed a positive shift within our department.”

Mahama’s impactful presence at UFS

Dr Von Maltitz emphasised that Mahama’s visit aimed to offer staff and students a glimpse into his artistic process and mindset. During his time at the UFS, Mahama, who was virtually overseeing his latest recent large-scale artwork titled Purple Hibiscus, which involved wrapping the Barbican Centre in London, engaged extensively with staff and students from the department about their research. He shared insights into his creative journey, presented select works, and conducted critique sessions with fourth year and postgraduate students, among other activities. Dr Von Maltitz believes this interaction, particularly with students, has significantly bolstered their confidence as aspiring artists, preparing them for professional endeavours.

Broader implications and future prospects

Mahama’s visit not only energised the department’s academic environment but also holds broader implications. Dr Von Maltitz asserted that it will solidify the department’s identity nationally and create avenues for students to pursue residencies in countries like Ghana. Therefore, maintaining a fruitful relationship with Mahama remains a priority for the department.

Reflecting on the visit Dr Von Maltitz concluded, ‘’the key takeaway, especially for the students, was witnessing the potential of their works within the broader South African and international contexts. “ 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept